Sera Prognostics (SERA) EBITDA Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | -3.08 Mn |
| Sep 30, 2025 | -114,522.00 |
| Jun 30, 2025 | -2.54 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | -1.11 Mn |
| Sep 30, 2024 | 914,842.00 |
| Dec 31, 2023 | -83,972.00 |
| Sep 30, 2023 | -828,304.00 |
| Jun 30, 2023 | 129,547.00 |
| Mar 31, 2023 | 466,362.00 |
| Dec 31, 2022 | -198,852.00 |
| Sep 30, 2022 | 226,083.00 |
| Jun 30, 2022 | 1.84 Mn |
| Mar 31, 2022 | 1.53 Mn |
| Dec 31, 2021 | -564,916.00 |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | 1.74 Mn |
| Mar 31, 2021 | 4.07 Mn |
| Dec 31, 2020 | 1.19 Mn |
| Sep 30, 2020 | -3.01 Mn |